Company profile
Solaris Vaccines company profile
Solaris Vaccines is a biotechnology company that develops therapeutic vaccines for infectious diseases. The Solaris SolaVAX method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new approach for creating vaccines against pathogens such as viruses, bacteria, and parasites.
Business identity
- Website
- https://solarisvax.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Fort Collins, Colorado, United States
- Country code
- US
- Continent
- North America